This is especially true for high-stage, aggressive, neuroblastoma where overexpression of survivin is frequently caused by a gain of chromosome 17q, suggesting that this protein represents a promising therapeutic target in malignant cells derived from neuronal precursors 3, 4. Here, BIRC5 is linked to neuroblastoma.